Jeffrey Jay increased its stake in Vanda Pharmaceuticals Inc. Cmn (VNDA) by 60.3% based on its latest 2017Q4 regulatory filing with the SEC. Great Point Partners Llc bought 300,000 shares as the company’s stock rose 9.54% while stock markets declined. The hedge fund run by Jeffrey Jay held 797,531 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $12.12 million, up from 497,531 at the end of the previous reported quarter. Great Point Partners Llc who had been investing in Vanda Pharmaceuticals Inc. Cmn for a number of months, seems to be bullish on the $745.18 million market cap company. The stock decreased 2.39% or $0.35 during the last trading session, reaching $14.3. About 328,689 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 15.63% since April 30, 2017 and is uptrending. It has outperformed by 4.08% the S&P500.
Oak Associates Ltd increased its stake in Check Point Software (CHKP) by 20.24% based on its latest 2017Q4 regulatory filing with the SEC. Oak Associates Ltd bought 25,610 shares as the company’s stock declined 2.77% with the market. The institutional investor held 152,120 shares of the prepackaged software company at the end of 2017Q4, valued at $15.76M, up from 126,510 at the end of the previous reported quarter. Oak Associates Ltd who had been investing in Check Point Software for a number of months, seems to be bullish on the $15.22 billion market cap company. The stock decreased 1.80% or $1.75 during the last trading session, reaching $95.73. About 1.45 million shares traded or 2.20% up from the average. Check Point Software Technologies Ltd. (NASDAQ:CHKP) has declined 4.45% since April 30, 2017 and is downtrending. It has underperformed by 16.00% the S&P500.
Since January 2, 2018, it had 0 insider purchases, and 8 insider sales for $4.89 million activity. 8,568 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares with value of $130,777 were sold by Birznieks Gunther. Another trade for 8,532 shares valued at $159,712 was made by Kelly James Patrick on Wednesday, February 28. Polymeropoulos Mihael Hristos sold $1.14M worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Wednesday, February 28.
Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 24 analyst reports since September 2, 2015 according to SRatingsIntel. As per Monday, September 4, the company rating was maintained by Jefferies. On Wednesday, November 9 the stock rating was initiated by Aegis Capital with “Buy”. The rating was initiated by Piper Jaffray with “Buy” on Tuesday, June 27. On Monday, October 30 the stock rating was maintained by Oppenheimer with “Outperform”. On Friday, August 26 the stock rating was maintained by JMP Securities with “Market Outperform”. Piper Jaffray maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Thursday, August 3 with “Buy” rating. The firm earned “Buy” rating on Thursday, August 3 by Oppenheimer. H.C. Wainwright maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Thursday, August 3 with “Buy” rating. Jefferies reinitiated Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Thursday, October 6 with “Buy” rating. The rating was maintained by JMP Securities with “Market Outperform” on Wednesday, March 9.
Great Point Partners Llc, which manages about $935.83M and $586.07M US Long portfolio, decreased its stake in Arena Pharmaceuticals Inc. Cmn by 180,681 shares to 1.18M shares, valued at $39.99 million in 2017Q4, according to the filing. It also reduced its holding in Global Blood Therapeutics Inc. Cmn (Call) by 360,498 shares in the quarter, leaving it with 200,000 shares, and cut its stake in Myovant Sciences Ltd Cmn.
Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.26, from 1.43 in 2017Q3. It worsened, as 19 investors sold VNDA shares while 34 reduced holdings. 16 funds opened positions while 46 raised stakes. 39.77 million shares or 2.28% more from 38.89 million shares in 2017Q3 were reported. Hbk Ltd Partnership accumulated 45,400 shares. Venbio Select Advisor Ltd Llc reported 1.39% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Panagora Asset Mgmt Inc accumulated 268,534 shares or 0.02% of the stock. Barclays Public Limited Co reported 0% stake. Los Angeles Management Equity has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Aqr Cap Mgmt Ltd Liability Corporation reported 0% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Prudential Fin stated it has 704,009 shares or 0.01% of all its holdings. The Pennsylvania-based Ajo Ltd Partnership has invested 0.03% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). State Board Of Administration Of Florida Retirement Sys reported 0% stake. 45,999 were reported by Clarivest Asset Mngmt Llc. Strs Ohio holds 56,200 shares. Bank & Trust Of Mellon Corp stated it has 200,361 shares. Rothschild Asset Management Inc, New York-based fund reported 1.37 million shares. State Street Corp owns 2.14M shares for 0% of their portfolio. Credit Suisse Ag reported 41,327 shares.
The post Great Point Partners Increases Position in Vanda Pharmaceuticals Cmn (VNDA); Check Point Software (CHKP) Position Maintained by Oak Associates Ltd appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/04/30/great-point-partners-increases-position-in-vanda-pharmaceuticals-cmn-vnda-check-point-software-chkp-position-maintained-by-oak-associates-ltd/
No comments:
Post a Comment